Cannagistics Inc (OTCMKTS: CNGT) heading north as Co prepares new product line for market and Global3PL gains traction


Cannagistics Inc (OTCMKTS: CNGT) has seen massive volume and price increases in recent days, from triple zero to recent highs of $ 0.024 per share. The stock quickly caught the eye of investors and some large small-cap players who were accumulating at current levels. We previously reported on CNGT on November 1, 2020 stating at the time: “Reverse Merge games are among the biggest runners in small cap competing only with biotech in their ability to achieve historic gains over time. CNGT has been heating up since the company recruited new CEO Jam Rob Gietl who was most recently, until March 2020, the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented products and patent pending in the health field. and wellness area. According to an 8k filed by PBIO; “Pressure BioSciences, Inc. has entered into a binding letter of intent to merge with Cannaworx Holdings, Inc. Pursuant to the Second Amendment, the parties have extended the deadline from September 30, 2020 to October 31, 2020.

It’s easy to see why investors are offering CNGT Higher; pink current, the company has behind it a stellar management team led by Jim Morrison who was previously president of L’Oréal for 9 years, he acquired Redken and Matrix and led an average growth of over 20%. They already have 4 products on the market including 2 that were previously approved by the FDA and are currently launching a number of new products. They also have a valuable intellectual property portfolio with numerous patents and patents pending. CNGT has an excellent share structure with 266,242,608 shares outstanding, of which 94,097,582 are restricted, leaving 172,327,026 free shares. CNGT trades on a total market capitalization of $ 3,274,784. CNGT topped $ 0.10 per share around the same time last year and investors are looking for a return to those levels and a breakout. CNGT has liquidity, momentum and a growing shareholder base that drives the stock higher.

Cannagistics, Inc. (OTC: CNGT) is an American company that operates both general and specialty 3PLs (third-party logistics) with an emphasis on supply chain management, reverse logistics, warehousing and transport, and is currently developing industry-specific technological platforms. The Company has a valuable intellectual property portfolio with numerous patents and patents pending.

Global3PL (Ontario, Canada) is the company’s general commodity operation, with warehouses in Canada and the United States providing monthly and just-in-time inventory, pick-up and shipping, customs brokerage, as well as international freight forwarding, expedited and delayed air transport services. , door-to-door pickup and delivery to local, regional and North American consumers, LTL (“LTL”), Full Truck (TL).

Cannagistics, Inc. (Canadian subsidiary of CNGT) is a cannabis-specific logistics company aimed at streamlining the fragmented cannabis market. The first Canadian company to obtain its own bonded warehouse license for cannabis, we are also developing the most robust supply chain technology platform specifically for the cannabis ecosystem – to exploit the huge opportunities in the global marketplace. Emerging Cannabis In an effort to solve problems, we will use technology to streamline the complexities of coordinating compliance (state-by-state and country-by-country), logistics, international approvals, information and tracking product shelf life, through the services of our knowledge-based operations team

The company has a stellar management team behind it; CEO Jim Morrison was previously President of L’Oréal for 9 years, he acquired Redken and Matrix and led average growth above 20%. As CEO, he led the first celebrity-focused video shopping app in partnership with SPRINT; Graham Webb, one of the most successful hair care startups; and Sexy Hair Concepts for four years.

For the inside scoop on CNGT, subscribe to Microcapdaily.com now by entering your email in the box below

CNGT

Dr. Babak “Bobby” Ghalili, DMD, is one of the leading periodontal and reconstructive dental surgeons in the field, he is an associate professor of periodontal surgery at New York University and the University of Medicine and New Jersey dentistry. Dr Ghalili is a graduate of Brandeis University, Tufts University and UMMDJ, and author of 21 patents (6 patents granted and 15 patents pending).

On January 3, CNGT announced that it was set to begin marketing and promoting its new product line in Q1 2022.

The Company’s current products include: (there is an excellent list of the company’s products and patents in their most recent version 10k)

ImmuniZinTM (Immune Booster) containing an FDA approved formulation and ingredient for immune boosting and T cell enhancement

Canagel® – (Composition and delivery system of anhydrous hydrogel). Revolutionary and patented oral transmucosal delivery of CBD / Phycannabionoids in the form of an oral strip that melts in the mouth.

Compositions and veterinary methods of cannabinoids and menthol

KidzStrips® Thin Film Toothpaste Strip, US Patent & European Patent

HydroSoil® – Improved water-retaining hemp fertilizer, water plants once every two weeks

IcyEase – Muscle / Joint Pain Adhesive Ice Pack to cool surface and relieve pain.

Slim-D – Oral appetite suppressant strip with 50 mg of Hoodia and 10 mg of full spectrum phytocannabinoid

Energy Lighting Strips – High Caffeine Fast Dissolving Oral Energy Strip with Matcha Green Tea and Full Spectrum Hemp / Phytocannabinoid

Silverpro – Revolutionary technology combining real silver thread with low static electricity carbon fibers, to create the world’s most advanced compression pain relief fabric.

Jim Morrison, President / CEO, said, “I am extremely excited to bring these revolutionary products to market. My experience and my background, as well as the years of contacts, allow me to capitalize on the relationships developed over the years to support the Company.

To learn more about CNGT, subscribe now!

CNGT has seen a massive increase in volume and prices in recent days, from triple zero to recent highs of $ 0.024 per share. The stock quickly caught the eye of investors and some large small-cap players who were accumulating at current levels. We previously reported on CNGT on November 1, 2020 stating at the time: “Reverse Merge games are among the biggest runners in small cap competing only with biotech in their ability to achieve historic gains over time. CNGT has been heating up since the company recruited new CEO Jam Rob Gietl who was most recently, until March 2020, the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented products and patent pending in the health field. and wellness area. According to an 8k filed by PBIO; “Pressure BioSciences, Inc. has entered into a binding letter of intent to merge with Cannaworx Holdings, Inc. Pursuant to the Second Amendment, the parties have extended the deadline from September 30, 2020 to October 31, 2020. It’s easy to see why investors are offering CNGT Higher; “Pink current” the company has behind it a stellar management team led by Jim Morrison who was president of L’Oréal for 9 years, he acquired Redken and Matrix and led an average growth of over 20%. They already have 4 products on the market including 2 that were previously approved by the FDA and are currently launching a number of new products. They also have a valuable intellectual property portfolio with numerous patents and patents pending. CNGT has an excellent share structure with 266,242,608 shares outstanding, of which 94,097,582 are restricted, leaving 172,327,026 free shares. CNGT trades on a total market capitalization of $ 3,274,784. CNGT topped $ 0.10 per share around the same time last year and investors are looking for a return to those levels and a breakout. CNGT has liquidity, momentum and a growing shareholder base that drives the stock higher. We’ll update CNGT when more details emerge, so make sure you’re subscribed to Microcapdaily so you know what’s going on with CNGT.

Disclosure: We do not hold any long or short positions in CNGT, and we were not paid for this article.



Comments are closed.